Skip to main content

Table 1 Patient characteristics

From: Dosimetric benefit of an adaptive treatment by means of plan selection for rectal cancer patients in both short and long course radiation therapy

nrAgeSexTumor stageTreatment schemeChemoGTV locationSurgeryBladder volume cm3 planning CTUpper mesorectum volume cm3 planning CTUpper mesorectum length mm planning CTAvailable margins (mm)Average bladder volume CBCT relative to planning CTAverage upper mesorectum volume CBCT relative to planning CT
165McT3N1M05 × 5 GyNproximalLAR18525955−150151.131.03
270FcT3N0M05 × 5 GyNmidLAR55814360015250.661.05
363McT4N1M05 × 5 GyYdistalns20326960−150150.841.06
471McT3N1M05 × 5 GyNmidLAR62218486015250.701.14
574McT3N0M05 × 5 GyNproximalLAR55722665015250.571.06
656FcT3N1M05 × 5 GyNmidLAR13515641−150150.421.02
773McT3N2M15 × 5 GyYproximalLAR16035771015251.020.97
870McT3N2M05 × 5 GyNdistalAPR29524465015250.591.03
940FcT3N1M05 × 5 GyNmidLAR94113157015250.521.25
1078McT4N1M05 × 5 GyNrectosigmoidLAR61328970015250.331.06
1171FcT3N1M025 × 2 GyYproximalLAR79139380−150150.630.71
1266McT3N2M025 × 2 GyYmidLAR15018546−150151.050.9
1364FcT3N2M025 × 2 GyYdistalAPR40322365015250.310.95
1465McT3N2M025 × 2 GyYproximalLAR44630965015250.651.09
1555FcT4N0M025 × 2 GyYdistalLAR59518667015250.420.91
1659McT3N0M025 × 2 GyYmidLAR16617052−150151.271.00
1772McT3N2M025 × 2 GyYproximalLAR42037385015250.651.05
1869FcT4N1M025 × 2 GyYmidLAR51144297015250.790.99
1977McT3N2M025 × 2 GyYdistalns45612858015250.551.10
2060McT3N2M025 × 2 GyYdistalns39226167−150150.750.92
  1. ns Not specified
  2. LAR Low anterior resection
  3. APR Abdominal perineal resection